Assessment of the Safety and Efficacy of the Novel Tetrapeptide ITF-1697 on Infarct Size after Primary PTCA in Acute Myocardial Infarction: A Randomised, Placebo-Controlled Pilot Trial

Author： Syeda B.   Kiss K.   Modarressy K.   Schönau K.   Schukro C.   Derntl M.   Laggner A.   Sochor H.   Glogar D.  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.5, Iss.3, 2004-01, pp. : 141-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ITF 1697: potential to reduce infarct size?

By  

Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Efficacy of Zolmitriptan at Early Time-Points for the Acute Treatment of Migraine and Treatment of Recurrence: A Randomised, Placebo-Controlled Trial

By Ryan R.E.J.  

CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 215-226

Adis International

Access to resources Recommend Favorite

Dependency on Infarct Size Limits the Clinical Applicability of Non-Invasive Reperfusion Assessment by Biochemical Markers in Acute Myocardial Infarction

By  

Heart Drug, Vol. 1, Iss. 4, 2001-10 ,pp. : 197-206

Karger

Access to resources Recommend Favorite

Safety and efficacy of tenecteplase in acute myocardial infarction

By Guerra Daniel R   Karha Juhana   Gibson C Michael  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 791-798

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of the Platelet-Activating Factor Receptor Antagonist BN 52021 (Ginkgolide B) in Patients with Severe Sepsis: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial

By Albrecht D.M.  

Clinical Drug Investigation, Vol. 24, Iss. 3, 2004-01 ,pp. : 137-147

Adis International

Access to resources Recommend Favorite